Abstract:Objective The purpose of the study was to determine the significance of heat shock protein 90 (HSP 90) and serum chemokine ligand 21 (CCL-21) in pregnant women with preeclampsia (PE). Methods From June 2021 to June 2022, the study enrolled 100 women undergoing obstetric examinations and delivering in our hospital; 50 PE patients undergoing routine obstetric examinations and delivering during the same period were enrolled in the research group; according to the severity, they were divided into mild PE and severe PE groups, while 50 healthy pregnant women undergoing obstetric examinations and delivering in our hospital during the same period were enrolled in the control group. In a subsequent analysis, serum levels of CCL-21 and HSP90 were compared between the two groups, and the correlation among CCL-21, HSP 90, and PE severity was analyzed. Results An overall total of 50 patients with PE were enrolled in the study, which included 32 patients with mild PE and 18 patients with severe PE. Patients with severe PE had lower mean arterial pressure (MAP), HSP 90, and CCL21 index levels than those with mild PE; MAP, HSP 90, and CCL21 in the severe PE group were higher than those in the mild PE group, but the difference was not statistically significant; In the research group, MAP was weakly correlated with HSP90 concentration and CCL21 concentration, with correlation coefficients of 0.33 and 0.30, respectively, and the correlation analysis was significant. Conclusion Patients with PE showed significantly increased serum concentrations of HSP90 and CCL-21, but a significant difference did not exist between mild and severe PE. In addition, there was a weak relationship between HSP90 and CCL-21 concentrations in PE patients and MAP, suggesting that HSP90 and CCL-21 play an instrumental role in the pathogenesis of PE, although more studies are needed to clarify the exact mechanisms.

Expression and significance of cathepsin C and cathepsin D during pregnancy and Preeclampsia

Expressions and significance of β-catenin and DKK-1 in preeclampsia of placental tissue

Changes of serum cardiotropin I and cystatin C in preeclampsia and significance thereof

[Changes of serum cardiotrophin I and cystatin C in preeclampsia and clinical significance thereof].

The Role of Catestatin in Preeclampsia

Changes of serum cardiotropin Ⅰ and cystatin C in preeclampsia and clinical significance thereof

Alteration of Serum Endocan in Normal Pregnancy and Preeclampsia

Association of a Reduction of G-protein Coupled Receptor 30 Expression and the Pathogenesis of Preeclampsia

Urinary concentration of Cathepsin D as a relievable marker of preeclampsia

[Expression of Fas and FasL in Serum and Placenta of Preeclamptic Pregnancy and Its Significance].

Elevated Serum Levels of Interleukin-15 and Interleukin-16 in Preeclampsia.

Dual specificity protein phosphatase 1 ( DUSP 1 ) in normal pregnancy and preeclampsia

A Study of Heat Shock Protein 90 and Serum CCL21 Expression in Pregnant Women with Preeclampsia

Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients

Comparative peptidomics analysis of preeclamptic placenta and the identification of a novel bioactive SERPINA1 C-terminal peptide

Distinct expression profiles of peptides in placentae from preeclampsia and normal pregnancies

Changes in expression levels of immune cells and inflammatory cytokines in pre-eclampsia patients before and after delivery

Up-regulation of CD81 Inhibits Cytotrophoblast Invasion and Mediates Maternal Endothelial Cell Dysfunction in Preeclampsia

Screening and Functional Analysis of the Differential Peptides from the Placenta of Patients with Healthy Pregnancy and Preeclampsia Using Placental Peptidome

Role of clusterin in the regulation of trophoblast development and preeclampsia

Effect of Pre-eclampsia Serum on Cytotrophoblast Invasive Ability and Endothelial Cell Apoptosis in a Model of Cytotrophoblast Coculture with Endothelial Cell